%A Liu Zhaoyun %T Expression and therapy of Prame gene on hematologic malignancies %0 Journal Article %D 2014 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2014.08.017 %P 611-614 %V 41 %N 8 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9463.shtml} %8 2014-08-15 %X As a member of the family of cancertestis antigen, preferentially expressed antigen of melanoma (Prame) can improve the proliferation of tumor via inhibiting the retinoic acid receptor signal path and impeding the transcription factor which is a wide range of physiological processes in development and differentiation of tumor cells. Prame expresses in solid tumors and hematological malignancies, which is widely used for tumor diagnosis, monitoring of tumor metastasis and immunotherapy.